Document Detail


Activation of the ERK signalling pathway contributes to the adaptive changes in rat hearts during naloxone-induced morphine withdrawal.
MedLine Citation:
PMID:  17549049     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND PURPOSE: We have previously demonstrated that morphine withdrawal induced hyperactivity of the heart by activation of noradrenergic pathways innervating the left and right ventricle, as evaluated by noradrenaline turnover and c-Fos expression. The extracellular signal-regulated kinase (ERK) has been implicated in drug addiction, but its role in activation of the heart during morphine dependence remains poorly understood. Here, we have looked for activation of ERK during morphine withdrawal and if this activation induced gene expression.
EXPERIMENTAL APPROACH: Dependence on morphine was induced by s.c. implantation of morphine pellets for 7 days. Morphine withdrawal was precipitated on day 8 by injection of naloxone (2 mg kg(-1), s.c.). ERK1/2, their phosphorylated forms and c-Fos were measured by western blotting and immunohistochemistry of cardiac tissue.
KEY RESULTS: Naloxone-induced morphine withdrawal activated ERK1/2 and increased c-Fos expression in cardiac tissues. c-Fos expression was blocked by SL327, a drug that prevents ERK activation.
CONCLUSIONS AND IMPLICATIONS: These results indicate that signalling through the ERKs is necessary for morphine withdrawal-induced hyperactivity of the heart and suggest that this pathway may also be involved in activation of immediate-early genes in both cytosolic and nuclear effector mechanisms that have the potential to bring about long-term changes in the heart.
Authors:
P Almela; M V Milanés; M L Laorden
Related Documents :
22993579 - Rho-kinase regulates prostaglandin d(2)-stimulated heat shock protein 27 induction in o...
23623499 - Mll-enl inhibits polycomb repressive complex 1 to achieve efficient transformation of h...
24283969 - Seeding collaborations to advance kinase science with the gsk published kinase inhibito...
24568369 - The acetyl-lysine binding site of bromodomain-containing protein 4 (brd4) interacts wit...
23845219 - Structure guided design of a series of sphingosine kinase (sphk) inhibitors.
12034879 - Basic fgf mediates an immediate response of articular cartilage to mechanical injury.
12882449 - N-acetylcysteine reduces chemokine release via inhibition of p38 mapk in human airway s...
1999479 - Epidermal growth factor-induced hydrolysis of phosphatidylcholine by phospholipase d an...
19686719 - The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-06-04
Journal Detail:
Title:  British journal of pharmacology     Volume:  151     ISSN:  0007-1188     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-07-16     Completed Date:  2007-11-02     Revised Date:  2013-06-06    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  787-97     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, University School of Medicine, Murcia, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aminoacetonitrile / analogs & derivatives
Animals
Blotting, Western
Extracellular Signal-Regulated MAP Kinases / metabolism*
Gene Expression / drug effects
Genes, fos / drug effects
Heart Ventricles / drug effects
Immunohistochemistry
MAP Kinase Signaling System / drug effects
Male
Morphine / adverse effects*
Naloxone / pharmacology*
Narcotic Antagonists / pharmacology*
Narcotics / adverse effects*
Phosphorylation / drug effects
Rats
Rats, Sprague-Dawley
Signal Transduction / drug effects
Substance Withdrawal Syndrome / metabolism*,  physiopathology
Chemical
Reg. No./Substance:
0/Narcotic Antagonists; 0/Narcotics; 0/SL 327; 465-65-6/Naloxone; 540-61-4/Aminoacetonitrile; 57-27-2/Morphine; EC 2.7.11.24/Extracellular Signal-Regulated MAP Kinases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective liga...
Next Document:  Double pharmacological challenge on repolarization opens new avenues for drug safety research.